TARDBP and hepatocellular carcinoma: Using three TNBC cell lines—HCC 70, MDA-MB-468, and MDA-MB-231—our data demonstrate that TARDBP mRNA levels were significantly reduced upon OGT inhibition (Fig. 2k–n).